Ameriprise’s China Life Insurance Company Ltd. LFC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-100,001
| Closed | -$864K | – | 4073 |
|
|
2022
Q2 | $864K | Buy |
100,001
+4,837
| +5% | +$36.9K | ﹤0.01% | 3182 |
|
|
2022
Q1 | $723K | Buy |
95,164
+9,987
| +12% | +$84.2K | ﹤0.01% | 3340 |
|
|
2021
Q4 | $700K | Buy |
85,177
+7,478
| +10% | +$64.2K | ﹤0.01% | 3406 |
|
|
2021
Q3 | $634K | Buy |
77,699
+30,831
| +66% | +$264K | ﹤0.01% | 3326 |
|
|
2021
Q2 | $467K | Buy |
46,868
+12,617
| +37% | +$129K | ﹤0.01% | 3481 |
|
|
2021
Q1 | $357K | Buy |
34,251
+18,457
| +117% | +$200K | ﹤0.01% | 3534 |
|
|
2020
Q4 | $175K | Buy |
15,794
+870
| +6% | +$9.95K | ﹤0.01% | 3636 |
|
|
2020
Q3 | $169K | Buy |
14,924
+2,250
| +18% | +$26.9K | ﹤0.01% | 3576 |
|
|
2020
Q2 | $128K | Sell |
12,674
-45,148
| -78% | -$454K | ﹤0.01% | 3559 |
|
|
2020
Q1 | $565K | Buy |
57,822
+11,607
| +25% | +$139K | ﹤0.01% | 3069 |
|
|
2019
Q4 | $640K | Sell |
46,215
-378
| -0.8% | -$4.84K | ﹤0.01% | 3249 |
|
|
2019
Q3 | $537K | Buy |
46,593
+4,053
| +10% | +$49.4K | ﹤0.01% | 3277 |
|
|
2019
Q2 | $530K | Sell |
42,540
-225
| -0.5% | -$2.86K | ﹤0.01% | 3322 |
|
|
2019
Q1 | $574K | Sell |
42,765
-1,876
| -4% | -$23.6K | ﹤0.01% | 3246 |
|
|
2018
Q4 | $467K | Buy |
44,641
+484
| +1% | +$5.15K | ﹤0.01% | 3212 |
|
|
2018
Q3 | $503K | Buy |
44,157
+2,690
| +6% | +$32K | ﹤0.01% | 3293 |
|
|
2018
Q2 | $541K | Buy |
41,467
+18,499
| +81% | +$258K | ﹤0.01% | 3228 |
|
|
2018
Q1 | $322K | Sell |
22,968
-523
| -2% | -$8.03K | ﹤0.01% | 3352 |
|
|
2017
Q4 | $367K | Sell |
23,491
-1,022
| -4% | -$16.6K | ﹤0.01% | 3303 |
|
|
2017
Q3 | $369K | Sell |
24,513
-3,481
| -12% | -$54.6K | ﹤0.01% | 3323 |
|
|
2017
Q2 | $433K | Buy |
27,994
+85
| +0.3% | +$1.32K | ﹤0.01% | 3289 |
|
|
2017
Q1 | $428K | Sell |
27,909
-597
| -2% | -$8.84K | ﹤0.01% | 3229 |
|
|
2016
Q4 | $367K | Buy |
28,506
+1,749
| +7% | +$23.1K | ﹤0.01% | 3404 |
|
|
2016
Q3 | $350K | Buy |
26,757
+1,211
| +5% | +$14.6K | ﹤0.01% | 3321 |
|
|
2016
Q2 | $281K | Buy |
25,546
+8,730
| +52% | +$97.8K | ﹤0.01% | 3413 |
|
|
2016
Q1 | $207K | Sell |
16,816
-6,238
| -27% | -$75.3K | ﹤0.01% | 3523 |
|
|
2015
Q4 | $369K | Sell |
23,054
-11,296
| -33% | -$201K | ﹤0.01% | 3401 |
|
|
2015
Q3 | $597K | Buy |
34,350
+1,664
| +5% | +$30.4K | ﹤0.01% | 3185 |
|
|
2015
Q2 | $711K | Buy |
32,686
+3,139
| +11% | +$74.7K | ﹤0.01% | 3285 |
|
|
2015
Q1 | $651K | Buy |
29,547
+714
| +2% | +$14.6K | ﹤0.01% | 3101 |
|
|
2014
Q4 | $564K | Buy |
28,833
+9,789
| +51% | +$154K | ﹤0.01% | 3076 |
|
|
2014
Q3 | $264K | Buy |
19,044
+4,113
| +28% | +$59.1K | ﹤0.01% | 3283 |
|
|
2014
Q2 | $195K | Buy |
14,931
+4,317
| +41% | +$58.2K | ﹤0.01% | 3335 |
|
|
2014
Q1 | $150K | Sell |
10,614
-24
| -0.2% | -$336 | ﹤0.01% | 3354 |
|
|
2013
Q4 | $167K | Buy |
10,638
+2,190
| +26% | +$31.7K | ﹤0.01% | 3205 |
|
|
2013
Q3 | $109K | Sell |
8,448
-1,692
| -17% | -$21.2K | ﹤0.01% | 3425 |
|
|
2013
Q2 | $118K | Buy |
+10,140
| New | +$132K | ﹤0.01% | 3310 |
|
Other funds holding LFC
HJIM
CCP
TRCT
BTI
IA
ACA
SSG
SPIA
Ameriprise's LFC Position: Q3 2022 in Review
Ameriprise sold out of China Life Insurance Company Ltd. (LFC) in Q3 2022, closing a stake of 100,001 shares — an estimated $864K sold.
Ameriprise first reported a position in LFC in Q2 2013 and held it in 37 quarters. The position peaked at $864K in Q2 2022. 13 funds tracked by Wall St. Rank hold LFC as of Q3 2022.
- Ameriprise reported no remaining China Life Insurance Company Ltd. position as of Q3 2022 after selling out during the quarter.
- Ameriprise sold 100,001 China Life Insurance Company Ltd. shares in Q3 2022, an estimated $864K.
- Ameriprise first reported a position in China Life Insurance Company Ltd. in Q2 2013 and held it in 37 quarters.
- Ameriprise's China Life Insurance Company Ltd. position peaked at $864K in Q2 2022.
- 13 funds tracked by Wall St. Rank held China Life Insurance Company Ltd. as of Q3 2022.
Based on Ameriprise's 13F filing for Q3 2022, filed 14 Nov 2022.